WuXia293Stable: Express What CHO Can't

As biologics become more structurally complex, developers are pushing expression systems further than ever before — and long‑relied‑upon platforms are beginning to reach their limits. This video introduces a new 293‑based stable expression system designed to meet those challenges head‑on. Built on the HEC 293 lineage, the platform brings together efficient transfection, controlled glycosylation, and reduced truncation to support cleaner, more predictable production of advanced biologics and vaccines.

Viewers will see how the system minimizes undesired glycosylation, improves molecular accuracy, and enhances biological activity — capabilities that offer new flexibility for teams facing expression bottlenecks or working with next‑generation constructs. The preview sets the stage for an inside look at how more precise, human‑relevant expression can strengthen development programs from the start.

Watch the full video to explore this emerging approach to high‑fidelity biologics manufacturing.